Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors

Immunology and Cell Biology

Volumn 94, Issue 6, 2016, Pages 573-582

  Szomolay, Barbara ^a,b   Liu, Jie ^c   Brown, Paul E ^a   Miles, John J ^d   Clement, Mathew ^b   Llewellyn Lacey, Sian ^b   Dolton, Garry ^b   Ekeruche Makinde, Julia ^e   Lissina, Anya ^f   Schauenburg, Andrea J ^b   Sewell, Andrew K ^b   Burrows, Scott R ^d   Roederer, Mario ^c   Price, David A ^b,c   Wooldridge, Linda ^f   Van Den Berg, Hugo A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN; VIRUS PROTEIN; HLA ANTIGEN CLASS 1; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; VIRAL PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; COMBINATORIAL PEPTIDE LIBRARY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE CLONE; PEPTIDE LIBRARY; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN DATABASE; CHEMISTRY; IMMUNOLOGY; METABOLISM; REPRODUCIBILITY; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DATABASES, PROTEIN; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; LIGANDS; PEPTIDE LIBRARY; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY; VIRAL PROTEINS;

EID: 84961899515     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.12     Document Type: Article

References (50)

1. Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, Van-Krinks C, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008; 118: 3390-3402
2. Kronenberg D, Knight RR, Estorninho M, Ellis RJ, Kester MG, de Ru A, et al. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes, and kill β-cells. Diabetes 2012; 61: 1752-1759
3. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset, and long-term type 1 diabetes patients. J Exp Med 2012; 209: 51-60
4. Friese MA, Fugger L. Pathogenic CD8+ T cells in multiple sclerosis. Ann Neurol 2009; 66: 132-141
5. Diani M, Altomare G, Reali E. T cell responses in psoriasis, and psoriatic arthritis. Autoimmun Rev 2015; 14: 286-292
6. Selin LK, Wlodarczyk MF, Kraft AR, Nie S, Kenney LL, Puzone R, et al. Heterologous immunity: immunopathology, autoimmunity, and protection during viral infections. Autoimmunity 2011; 44: 328-347
7. Coppieters KT, Wiberg A, von Herrath MG. Viral infections, and molecular mimicry in type 1 diabetes. APMIS 2012; 120: 941-949
8. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705
9. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, et al. Identification of high potency microbial, and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997; 185: 1651-1659
10. Rodríguez-Caballero A, García-Montero AC, Bárcena P, Almeida J, Ruiz-Cabello F, Tabernero MD, et al. Expanded cells in monoclonal TCR-αβ+/CD4+/NKa+/CD8- /+ dim T-LGL lymphocytosis recognize hCMV antigens. Blood 2008; 112: 4609-4616
11. Melenhorst JJ, Brümmendorf TH, Kirby M, Lansdorp PM, Barrett AJ. CD8+ T cells in large granular lymphocyte leukemia are not defective in activation-and replicationrelated apoptosis. Leuk Res 2001; 25: 699-708
12. Melenhorst JJ, Sorbara L, Kirby M, Hensel NF, Barrett AJ. Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory, and effector CD8+ lymphocyte populations. Br J Haematol 2001; 112: 189-194
13. Melenhorst JJ, Eniafe R, Follmann D, Molldrem J, Kirby M, El Ouriaghli F, et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion, and a generalized overexpression of the effector cell marker CD57. Hematol J 2003; 4: 18-25
14. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, et al. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia 2009; 23: 1398-1405
15. Kreutzman A, Ladell K, Koechel C, Gostick E, Ekblom M, Stenke L, et al. Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. Leukemia 2011; 25: 1587-1597
16. González-Quintial R, Baccalá R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 1996; 97: 1335-1343
17. Risitano AM, Kook H, Zeng W, Chen G, Young NS, Maciejewski JP. Oligoclonal, and polyclonal CD4, and CD8 lymphocytes in aplastic anemia, and paroxysmal nocturnal hemoglobinuria measured by Vβ CDR3 spectratyping, and flow cytometry. Blood 2002; 100: 178-183
18. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human αβ T cell receptor diversity. Science 1999; 286: 958-961
19. Wooldridge L, Ekeruche-Makinde J, Van den Berg HA, Skowera A, Miles JJ, Tan MP, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012; 287: 1168-1177
20. Wooldridge L. Individual MHCI-restricted T-cell receptors are characterized by a unique peptide recognition signature. Front Immunol 2013; 4: 199
21. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998; 19: 395-404
22. Ignatowicz L, Rees W, Pacholczyk R, Ignatowicz H, Kushnir E, Kappler J, et al. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997; 7: 179-186
23. Pinilla C, Martin R, Gran B, Appel JR, Boggiano C, Wilson DB, et al. Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol 1999; 11: 193-202
24. Nino-Vasquez JJ, Allicotti G, Borras E, Wilson DB, Valmori D, Simon R, et al. A powerful combination: the use of positional scanning libraries, and biometrical analysis to identify cross-reactive T cell epitopes. Mol Immunol 2004; 40: 1063-1074
25. Ekeruche-Makinde J, Miles JJ, Van den Berg HA, Skowera A, Cole DK, Dolton G, et al. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood 2013; 121: 1112-1123
26. Varani S, Landini MP. Cytomegalovirus-induced immunopathology, and its clinical consequences. Herpesviridae 2011; 2: 6
27. Lossius A, Johansen JN, Vartdal F, Robins H, Jurat.eŠaltyt.e B, Holmøy T, et al. Highthroughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells. Eur J Immunol 2014; 44: 3439-3452
28. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid, and blood. Proc Natl Acad Sci USA 2004; 101: 2428-2433
29. Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes?. Trends Immunol 2006; 27: 11-16
30. Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist, and antagonist peptides. Eur J Immunol 1997; 27: 2323-2329
31. Price DA, Sewell AK, Dong T, Tan R, Goulder PJ, Rowland-Jones SL, et al. Antigenspecific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr Biol 1998; 8: 355-358
32. Wooldridge L, Laugel B, Ekeruche J, Clement M, Van den Berg HA, Price DA, et al. CD8 controls T cell cross-reactivity. J Immunol 2010; 185: 4625-4632
33. Purbhoo MA, Li Y, Sutton DH, Brewer JE, Gostick E, Bossi G, et al. The HLA A∗0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol Cancer Ther 2007; 6: 2081-2091
34. Ekeruche-Makinde J, Clement M, Cole DK, Edwards ES, Ladell K, Miles JJ, et al. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem 2012; 287: 37269-37281
35. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M, et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 2005; 202: 1349-1361
36. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991; 354: 453-459
37. Iglesias MC, Almeida JR, Fastenackels S, Van Bockel DJ, Hashimoto M, Venturi V, et al. Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 2011; 118: 2138-2149
38. Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol 2012; 13: 691-700
39. Zhao Y, Gran B, Pinilla C, Markovic-Plese S, Hemmer B, Tzou A, et al. Combinatorial peptide libraries, and biometric score matrices permit the quantitative analysis of specific, and degenerate interactions between clonotypic TCR, and MHC peptide ligands. J Immunol 2001; 167: 2130-2141
40. Rubio-Godoy V, Ayyoub M, Dutoit V, Servis C, Schink A, Rimoldi D, et al. Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity. Eur J Immunol 2002; 32: 2292-2299
41. Clement M, Ladell K, Ekeruche-Makinde J, Miles JJ, Edwards ES, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement, and improve peptide-MHCI tetramer staining. J Immunol 2011; 187: 654-663
42. Miles JJ, Borg NA, Brennan RM, Tynan FE, Kjer-Nielsen L, Silins SL, et al. TCRα genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol 2006; 177: 6804-6814
43. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement, and T-cell immunodominance. J Biol Chem 2005; 280: 23900-23909
44. Goulder PJ, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, et al. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A∗0201 are influenced by epitope mutation. J Exp Med 1997; 185: 1423-1433
45. Laugel B, Van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, et al. Different T cell receptor affinity thresholds, and CD8 coreceptor dependency govern cytotoxic T lymphocye activation, and tetramer binding properties. J Biol Chem 2007; 282: 23799-23810
46. Cole DK, Edwards ES, Wynn KK, Clement M, Miles JJ, Ladell K, et al. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding, and T cell recognition. J Immunol 2010; 185: 2600-2610
47. Wooldridge L, Lissina A, Vernazza J, Gostick E, Laugel B, Hutchinson SL, et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol 2007; 37: 1323-1333
48. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995; 375: 148-151
49. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity, and specificity of antigen recognition. Immunol Today 1997; 18: 299-304
50. Van den Berg HA, Rand DA. Quantitative theories of T-cell responsiveness. Immunol Rev 2007; 216: 81-92